From
StayCurrentMD
Are Low Weight or Cardiopathy Contraindications for Thoracoscopic Repair of Esophageal Atresia with Tracheoesophageal Fistula?
dx.doi.org shows its articles on its own site.
Read the article on dx.doi.org ↗Article · May 2023 · 1 min read
In brief
In brief
This retrospective study demonstrates that thoracoscopic repair of esophageal atresia with tracheoesophageal fistula is safe and feasible in neonates with low birth weight (<2000g) or major congenital heart disease, showing comparable outcomes to standard-risk patients. The findings support expanding surgical candidacy while emphasizing individualized case selection.
- Thoracoscopic EA/TEF repair is feasible in neonates with major congenital heart disease without increased complications or conversion rates.
- Low birth weight (<2000g) is not an absolute contraindication; only 1/25 patients required conversion due to anesthetic intolerance at 1050g.
- Operative time, anastomotic outcomes, and stricture rates were comparable between high-risk (CHD/LBW) and standard-risk patient groups.
- No TEF recurrence occurred in either group, supporting thoracoscopic approach safety when individualized appropriately.
- Patient selection remains critical—individualize indication based on anesthetic tolerance and institutional expertise with complex cases.
Written by the GCMD Library team from the article.
Background Thoracoscopic repair of esophageal atresia (EA) with tracheoesophageal fistula (TEF) is becoming an increasingly widespread technique; there is still controversy about its indication in certain patients. Our objective is to analyze if potential risk factors such as major congenital heart disease (CHD) or low birth weight (LBW) are a limitation to this approach. Methods Retrospective study (2017–2021) of patients with EA and distal TEF who underwent thoracoscopic repair were included. Patients with LBW less than 2,000 g or major CHD were compared with the rest. Results Twenty-five patients underwent thoracoscopic surgery. Nine patients (36%) had major CHD. Five of them (20%) were LBW less than 2,000 g, and only 8% (2/25) presented both risk factors. There were no differences in terms of operative time, conversion rate, tolerance evaluated with gasometric parameters (pO2, pCO2, pH) or complications (anastomotic leak and stricture, both early or during follow-up) in patients with major CHD and LBW (1,473 ± 319 vs. 2,664 ± 402 g). One conversion to thoracotomy was performed in a neonate weighing 1,050 g due to anesthetic intolerance. There was no recurrence of TEF. One patient died at the age of 9 months, due to major uncorrectable heart disease. Conclusion Thoracoscopic repair of EA/TEF is feasible technique in patients with CHD or LBW, with similar results to other patients. The complexity of this technique warrants individualizing the indication in each case. Level of Evidence IV.
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Article
The disproportionate burden of severe obesity in youth with special needs and the role of metabolic and bariatric surgery
Published Jun 2026
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Article
Type of pledget and suture technique relative to esophageal tensile strength in long-gap esophageal atresia
Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026